Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02089555 · ClinicalTrials.gov registry record

African American Alzheimer's Progression Markers - CSF and Neuro-Imaging

A clinical trial, sponsored by Emory University.

Completed
Registry status
135
Enrollment target

NCT02089555: Completed study, sponsored by Emory University.

NCT02089555 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 135 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02089555 has completed, sponsored by Emory University.

COMPLETED
Registry status
135 participants
Enrollment target

Study Summary

African Americans are twice as likely to develop Alzheimer's disease as white Americans, but few African Americans are enrolled in large Alzheimer's biomarker studies. The current proposal aims to determine the influence of Alzheimer's disease and vascular disease on memory and aging in African Americans through modern biomarkers (spinal fluid, MRI, and amyloid imaging), and how these may differ between African Americans and white Americans in preparation for a large multi-center study of aging in African American.

Interventions

  • PROCEDURE Magnetic Resonance Imaging (MRI)
  • PROCEDURE Blood draw
  • PROCEDURE Lumbar puncture

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2013-09
Est. Completion 2016-06
Emory University

1,208 total trials

What the finished NCT02089555 record still lists

NCT02089555 is an observational study that tracks outcomes without assigning an intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.

NCT02089555 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02089555 about?

NCT02089555 is a clinical study titled "African American Alzheimer's Progression Markers - CSF and Neuro-Imaging". African Americans are twice as likely to develop Alzheimer's disease as white Americans, but few African Americans are enrolled in large Alzheimer's biomarker studies. The current proposal aims to determine the influence of Alzheimer's disease and vascular disease on memory and aging in African Amer...

What is the current status of trial NCT02089555?

This trial is currently completed. The enrollment target is 135 participants. The study started on 2013-09. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02089555?

The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Blood draw (PROCEDURE), Lumbar puncture (PROCEDURE).

Who is sponsoring clinical trial NCT02089555?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00870129 · 135 participants · NA

    Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

  • NCT03666000 · 135 participants · Phase 1

    Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • NCT04891510 · 135 participants · NA

    A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

  • NCT05121051 · 135 participants · Phase 2

    Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02089555, the US trial registry maintained by the National Library of Medicine. NCT02089555 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.